Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Brain Mapping Method Allows Neuroscientists To Track Individual Neurons

XTALKS VITALS NEWS

Wal-Mart

A new brain mapping method used in the mouse brain, will allow neuroscientists to study the brain at the resolution of single neurons.

Tweetables from this article:

Tweet: The technique could allow them to determine how gene mutations affect the brain’s circuitry, and what affect this has on brain function. This technique could allow them to determine how gene mutations affect the brain’s circuitry, and what affect this has on brain function.

Share this!

August 30, 2016 | by Sarah Massey, M.Sc.

A new brain mapping method used in the mouse brain, will allow neuroscientists to study the brain at the resolution of single neurons. The details of this technique were published in the journal, Neuron.

Multiplexed Analysis of Projections by Sequencing – or MAPseq – will allow researchers to trace many individual neurons in a single experiment. The technique promises to be less expensive, times-consuming and labor-intensive, compared to current brain mapping technologies.

Microscopes and other optical equipment are currently needed to generate wiring maps known as “connectomes,” which attempt to trace the links between neurons. According to Dr. Anthony Zador, professor at Cold Spring Harbor Laboratory and inventor of the technique, MAPseq is the first tool which, “converts the task of brain mapping into one of RNA sequencing.”

“The RNA sequences, or 'barcodes,' that we deliver to individual neurons are unmistakably unique,” said Zador, “and this enables us to determine if individual neurons, as opposed to entire regions, are tailored to specific targets.”

Most methods aside from MAPseq use “bulk tracing,” in which a neuron is engineered to express a fluorescent protein which is carried along the axon. While these markers can identify where in the brain each neuron projects to, it cannot identify whether two neurons in the same region project to the same area of the brain.

Zador explains the differences between MAPseq and conventional bulk tracing using an airport analogy. “If you go to the international terminal, you see a long line of ticket counters,” said Zador. “If you want to go to Germany, it's not enough to take any airline at the international terminal. If you stand in line at the counter for Air Chile, you're probably not going to be able to buy a ticket for Germany.

“Those many airlines whose counters are adjacent serve many destinations, some of which overlap, some of which are unique. You can print out a map showing all of the foreign countries that all of the airlines serve from your airport, but that doesn't tell you anything at all about individual airlines and where they go. This is the difference between current labeling methods and MAPseq. The 'individual airlines' in my example are adjacent neurons in a part of the brain whose 'routes' we want to trace.”

The result of years of research conducted by Zador and his team, the technology assigns unique identifiers to individual neurons following an injection into a prespecified region of the brain. The injection contains a deactivated virus which carries large numbers of unique RNA molecules. Each 30-nucleotide RNA sequence is absorbed by an individual neuron.

Inside each neuron, the RNA molecule migrates to the end of the axon where a synapse has been formed with another neuron. After multiple injections the brain is dissected, allowing researchers to collect and sequence the RNA barcodes. RNA sequences found in the brain region where they were injected are compared to those found in more distant areas of the brain, allowing neuroscientists to identify the sites in which each neuron’s projections can be found.

Zador and his colleagues plan to use MAPseq to study animal models of neurodevelopmental and neuropsychiatric illnesses. The technique could allow them to determine how gene mutations affect the brain’s circuitry, and what affect this has on brain function.


Keywords: RNA Sequencing, Neuron, Brain Mapping


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Lavazza Acquires Controlling Stake in Canada’s Kicking Horse Coffee

May 26, 2017 - Italian coffee company Lavazza, has secured an 80 percent equity stake in Canadian organic and fair-trade coffee company Kicking Horse Coffee, in a deal worth CAD$215 million.

Featured In: Food News


FDA First: Keytruda Approved for Cancer Treatment Based on Biomarker Alone

May 25, 2017 - For the first time, the FDA has approved a cancer treatment for solid tumors based on the presence of a biomarker, as opposed to specifying a tissue of origin.

Featured In: Biotech News


One Year of Medically Assisted Dying in Canada

May 25, 2017 - In June of 2016, the federal government of Canada passed legislation to legalize medically assisted dying.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Life Sciences During the Last Week

REGISTER FOR THESE WEBINARS

EU IVD Regulation: Top Five Changes for Medical Device Manufacturers to Consider


Thermal Processing Systems for the Food Industry: A Guide to Selecting Thermal Equipment and Technology


Rare Disease & Orphan Drug Development: Cost-Efficient Trial Design to Minimize Cash Burn


eTMF Workflows: Active eTMF to Improve the Quality of Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.